<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>RETIN-AÂ - tretinoinÂ creamÂ </strong><br><strong>RETIN-AÂ - tretinoinÂ gelÂ </strong><br>Physicians Total Care, Inc.<br></p></div>
<h1></h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-1"></a><p></p>
<p class="First"><span class="Bold">For Topical Use Only</span></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="section-2"></a><p></p>
<h1>DESCRIPTION</h1>
<p class="First">RETIN-A Gel, Cream and Liquid, containing tretinoin are used for the topical 
treatment of <span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">acne vulgaris</span>. RETIN-A Gel contains tretinoin (retinoic acid, 
vitamin A acid) in either of two strengths, 0.025% or 0.01% by weight, in a gel 
vehicle of butylated hydroxytoluene, hydroxypropyl cellulose and alcohol 
(denatured with <span class="Italics">tert-</span>butyl alcohol and brucine 
sulfate) 90% w/w. RETIN-A (tretinoin) Cream contains tretinoin in either of 
three strengths, 0.1%, 0.05%, or 0.025% by weight, in a hydrophilic cream 
vehicle of stearic acid, isopropyl myristate, polyoxyl 40 stearate, stearyl 
alcohol, xanthan gum, sorbic acid, butylated hydroxytoluene, and purified water. 
RETIN-A Liquid contains tretinoin 0.05% by weight, polyethylene glycol 400, 
butylated hydroxytoluene and alcohol (denatured with <span class="Italics">tert-</span>butyl alcohol and brucine sulfate) 55%. Chemically, 
tretinoin is <span class="Italics">all-trans-</span>retinoic acid and has the 
following structure:</p>
<div class="Figure"><img alt="image of chemical structure" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=0ee4fccd-087f-4134-9b66-1d5186c116c0&amp;name=chemical%20structure.jpg"></div>
<p><br></p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="section-3"></a><p></p>
<h1>CLINICAL PHARMACOLOGY</h1>
<p class="First">Although the exact mode of action of tretinoin is unknown, current evidence 
suggests that topical tretinoin decreases cohesiveness of follicular epithelial 
cells with decreased microcomedo formation. Additionally, tretinoin stimulates 
mitotic activity and increased turnover of follicular epithelial cells causing 
extrusion of the comedones.</p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="section-4"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<p class="First">RETIN-A is indicated for topical application in the treatment of <span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">acne vulgaris</span>. 
The safety and efficacy of the long-term use of this product in the treatment of 
other disorders have not been established.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="section-5"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First">Use of the product should be discontinued if <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to any of the 
ingredients is noted.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="section-6"></a><p></p>
<h1>PRECAUTIONS</h1>
<p class="First"><span class="Italics">General:</span> If a reaction suggesting 
sensitivity or chemical irritation occurs, use of the medication should be 
discontinued. Exposure to sunlight, including sunlamps, should be minimized 
during the use of RETIN-A, and patients with sunburn should be advised not to 
use the product until fully recovered because of heightened susceptibility to 
sunlight as a result of the use of tretinoin. Patients who may be required to 
have considerable sun exposure due to occupation and those with inherent 
sensitivity to the sun should exercise particular caution. Use of sunscreen 
products and protective clothing over treated areas is recommended when exposure 
cannot be avoided. Weather extremes, such as <span class="product-label-link" type="condition" conceptid="4221803" conceptname="Flatus">wind</span> or <span class="product-label-link" type="condition" conceptid="260427" conceptname="Common cold">cold</span>, also may be 
irritating to patients under treatment with tretinoin.</p>
<p>RETIN-A (tretinoin) <span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">acne</span> treatment should be kept away from the eyes, the 
mouth, angles of the nose, and mucous membranes. Topical use may induce severe 
local <span class="product-label-link" type="condition" conceptid="137193" conceptname="Erythema">erythema</span> and <span class="product-label-link" type="condition" conceptid="4032013" conceptname="Desquamation">peeling</span> at the site of application. If the degree of local 
irritation warrants, patients should be directed to use the medication less 
frequently, discontinue use temporarily, or discontinue use altogether. 
Tretinoin has been reported to cause severe irritation on eczematous skin and 
should be used with utmost caution in patients with this condition.</p>
<a href="http://"></a><p><span class="Italics">Drug Interactions:</span> Concomitant topical 
medication, medicated or abrasive soaps and cleansers, soaps and cosmetics that 
have a strong drying effect, and products with high concentrations of alcohol, 
astringents, spices or lime should be used with caution because of possible 
interaction with tretinoin. Particular caution should be exercised in using 
preparations containing sulfur, resorcinol, or salicylic acid with RETIN-A. It 
also is advisable to â€œrestâ€? a patient's skin until the effects of such 
preparations subside before use of RETIN-A is begun.</p>
<a href="http://"></a><p><span class="Italics">Carcinogenesis:</span> Long-term animal 
studies to determine the carcinogenic potential of tretinoin have not been 
performed. Studies in hairless albino mice suggest that tretinoin may accelerate 
the tumorigenic potential of weakly carcinogenic light from a solar simulator. 
In other studies, when lightly pigmented hairless mice treated with tretinoin 
were exposed to carcinogenic doses of UVB light, the incidence and rate of 
development of <span class="product-label-link" type="condition" conceptid="135777" conceptname="Neoplasm of uncertain behavior of skin">skin tumors</span> was reduced. Due to significantly different 
experimental conditions, no strict comparison of these disparate data is 
possible. Although the significance of these studies to man is not clear, 
patients should avoid or minimize exposure to sun.</p>
<a href="http://"></a><p><span class="Italics">Pregnancy:</span> Teratogenic effects. 
Pregnancy Category C. <span class="Underline">Oral</span> tretinoin has been shown 
to be teratogenic in rats when given in doses 1000 times the topical human dose. 
Oral tretinoin has been shown to be fetotoxic in rats when given in doses 500 
times the topical human dose.</p>
<p><span class="Underline">Topical</span> tretinoin has not been shown to be 
teratogenic in rats and rabbits when given in doses of 100 and 320 times the 
topical human dose, respectively (assuming a 50 kg adult applies 250 mg of 0.1% 
cream topically). However, at these topical doses, delayed ossification of a 
number of bones occurred in both species. These changes may be considered 
variants of normal development and are usually corrected after weaning. There 
are no adequate and well-controlled studies in pregnant women. Tretinoin should 
be used during pregnancy only if the potential benefit justifies the potential 
risk to the fetus.</p>
<a href="http://"></a><p><span class="Italics">Nursing Mothers:</span> It is not known 
whether this drug is excreted in human milk. Because many drugs are excreted in 
human milk, caution should be exercised when RETIN-A is administered to a 
nursing woman.</p>
<p><span class="Bold">GELS ARE FLAMMABLE.</span> Note: Keep away from heat and 
flame. Keep tube tightly closed.</p>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="section-7"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<p class="First">The skin of certain sensitive individuals may become excessively red, edematous, 
blistered, or crusted. If these effects occur, the medication should either be 
discontinued until the integrity of the skin is restored, or the medication 
should be adjusted to a level the patient can tolerate. True contact <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">allergy</span> to 
topical tretinoin is rarely encountered. Temporary hyper or hypopigmentation has 
been reported with repeated application of RETIN-A. Some individuals have been 
reported to have heightened susceptibility to sunlight while under treatment 
with RETIN-A. To date, all adverse effects of RETIN-A have been reversible upon 
discontinuance of therapy (see <a href="#section-10">Dosage and Administration 
Section</a>).</p>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="section-8"></a><p></p>
<h1>OVERDOSAGE</h1>
<p class="First">If medication is applied excessively, no more rapid or better results will be 
obtained and marked <span class="product-label-link" type="condition" conceptid="137193" conceptname="Erythema">redness</span>, <span class="product-label-link" type="condition" conceptid="4032013" conceptname="Desquamation">peeling</span>, or <span class="product-label-link" type="condition" conceptid="4090431" conceptname="Discomfort">discomfort</span> may occur. Oral ingestion of 
the drug may lead to the same side effects as those associated with excessive 
oral intake of Vitamin A</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="section-9"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<p class="First">RETIN-A Gel, Cream or Liquid should be applied once a day, before 
retiring, to the skin where <span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">acne</span> lesions appear, using enough to cover the 
entire affected area lightly. Liquid: The liquid may be applied using a 
fingertip, gauze pad, or cotton swab. If gauze or cotton is employed, care 
should be taken not to oversaturate it to the extent that the liquid would run 
into areas where treatment is not intended. Gel: Excessive application results 
in â€œpillingâ€? of the gel, which minimizes the likelihood of over application by 
the patient.</p>
<p>Application may cause a transitory <span class="product-label-link" type="condition" conceptid="4141161" conceptname="Hot">feeling of warmth</span> or slight <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">stinging</span>. In 
cases where it has been necessary to temporarily discontinue therapy or to 
reduce the frequency of application, therapy may be resumed or frequency of 
application increased when the patients become able to tolerate the 
treatment.</p>
<p>Alterations of vehicle, drug concentration, or dose frequency should be 
closely monitored by careful observation of the clinical therapeutic response 
and skin tolerance.</p>
<p>During the early weeks of therapy, an <span class="Italics">apparent</span> 
exacerbation of inflammatory lesions may occur. This is due to the action of the 
medication on deep, previously unseen lesions and should not be considered a 
reason to discontinue therapy.</p>
<p>Therapeutic results should be noticed after two to three weeks but more than 
six weeks of therapy may be required before definite beneficial effects are 
seen.</p>
<p>Once the <span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">acne</span> lesions have responded satisfactorily, it may be possible to 
maintain the improvement with less frequent applications, or other dosage 
forms.</p>
<p>Patients treated with RETIN-A (tretinoin) <span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">acne</span> treatment may use cosmetics, 
but the area to be treated should be cleansed thoroughly before the medication 
is applied. <span class="Bold">(See <a href="#section-7">Precautions.</a>)</span></p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="section-10"></a><p></p>
<h1>HOW SUPPLIED</h1>
<p class="First"><span class="Bold">RETIN-A (tretinoin) is supplied as:</span></p>
<a name="iac37cd38-812b-4cb1-89b7-b6940e36d61c"></a><table width="60%"><tbody class="Headless">
<tr class="First">
<td>
<span class="Bold">RETIN-A Cream</span><br>
</td>
<td><br></td>
<td><br></td>
</tr>
<tr>
<td><br></td>
<td>RETIN-A<br>
</td>
<td>RETIN-A<br>
</td>
</tr>
<tr>
<td>NDC Code<br>
</td>
<td>Strength/Form<br>
</td>
<td>Quantity<br>
</td>
</tr>
<tr>
<td>54868-1760-1<br>
</td>
<td>0.025%<br>
</td>
<td>Cream - 20g<br>
</td>
</tr>
<tr>
<td>54868-1760-2<br>
</td>
<td>0.025%<br>
</td>
<td>Cream - 45g<br>
</td>
</tr>
<tr>
<td>54868-0267-1<br>
</td>
<td>0.05%<br>
</td>
<td>Cream - 20g<br>
</td>
</tr>
<tr>
<td>54868-0267-2<br>
</td>
<td>0.05%<br>
</td>
<td>Cream - 45g<br>
</td>
</tr>
<tr>
<td>54868-0268-1<br>
</td>
<td>0.1%<br>
</td>
<td>Cream - 20g<br>
</td>
</tr>
<tr>
<td>54868-0268-2<br>
</td>
<td>0.1%<br>
</td>
<td>Cream - 45g<br>
</td>
</tr>
<tr>
<td><br></td>
<td><br></td>
<td><br></td>
</tr>
<tr>
<td>
<span class="Bold">RETIN-A Gel</span><br>
</td>
<td><br></td>
<td><br></td>
</tr>
<tr>
<td>54868-0269-2<br>
</td>
<td>0.01%<br>
</td>
<td>Gel - 15g<br>
</td>
</tr>
<tr class="Last">
<td>54868-0270-1<br>
</td>
<td>0.025%<br>
</td>
<td>Gel - 45g<br>
</td>
</tr>
</tbody></table>
<br><a href="#section-"></a><p><span class="Bold">Storage Conditions:</span> RETIN-A Liquid, 
0.05%, and RETIN-A Gel, 0.025% and 0.01%: store below 86Â°F. RETIN-A Cream, 0.1%, 
0.05%, and 0.025%: store below 80Â°F.</p>
<p>ORTHO DERMATOLOGICAL</p>
<p>Division of Ortho-McNeil</p>
<p>Pharmaceutical, Inc.</p>
<p>Skillman, New Jersey 08558</p>
<p>Â©OMP 2001 Revised February 2001 Printed in U.S.A. 643-10-490-9</p>
</div>
<div class="Section" data-sectionCode="34076-0">
<a name="section-11"></a><p></p>
<a href="#section-12"></a>PATIENT INSTRUCTIONS<p class="First">Retin-A<span class="Sup">Â®</span><br>(tretinoin)<br></p>
<p><span class="Bold"><span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">Acne</span> Treatment</span></p>
<p><span class="Bold">IMPORTANT</span></p>
<p>Read Directions Carefully Before Using</p>
<p>Cream Â· Gel Â· Liquid</p>
<p><span class="Bold">For Topical Use Only</span></p>
<p><span class="Bold">THIS LEAFLET TELLS YOU ABOUT RETIN-A (TRETINOIN) <span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">ACNE</span> 
TREATMENT AS PRESCRIBED BY YOUR PHYSICIAN. THIS PRODUCT IS TO BE USED ONLY 
ACCORDING TO YOUR DOCTOR'S INSTRUCTIONS, AND IT SHOULD NOT BE APPLIED TO OTHER 
AREAS OF THE BODY OR TO OTHER GROWTHS OR LESIONS. THE LONG-TERM SAFETY AND 
EFFECTIVENESS OF THIS PRODUCT IN OTHER DISORDERS HAVE NOT BEEN EVALUATED. IF YOU 
HAVE ANY QUESTIONS, BE SURE TO ASK YOUR DOCTOR.</span></p>
<p><span class="Bold">WARNINGS AND PRECAUTIONS</span></p>
<p><span class="Bold">The effects of the sun on your skin.</span> As you know, 
overexposure to natural sunlight or the artificial sunlight of a sunlamp can 
cause sunburn. Overexposure to the sun over many years may cause <span class="product-label-link" type="condition" conceptid="4227583" conceptname="Premature aging">premature aging</span> 
of the skin and even skin cancer. The chance of these effects occurring will 
vary depending on skin type, the climate and the care taken to avoid 
overexposure to the sun. Therapy with RETIN-A may make your skin more 
susceptible to sunburn and other adverse effects of the sun, so unprotected 
exposure to natural or artificial sunlight should be minimized.</p>
<p><span class="Bold">Laboratory findings.</span><span class="Italics">When 
laboratory mice are exposed to artificial sunlight, they often develop skin 
tumors. These sunlight-induced tumors may appear more quickly and in greater 
number if the mouse is also topically treated with the active ingredient in 
RETIN-A, tretinoin. In some studies, under different conditions, however, when 
mice treated with tretinoin were exposed to artificial sunlight, the incidence 
and rate of development of <span class="product-label-link" type="condition" conceptid="135777" conceptname="Neoplasm of uncertain behavior of skin">skin tumors</span> was reduced. There is no evidence to date 
that tretinoin alone will cause the development of <span class="product-label-link" type="condition" conceptid="135777" conceptname="Neoplasm of uncertain behavior of skin">skin tumors</span> in either 
laboratory animals or humans. However, investigations in this area are 
continuing.</span></p>
<p><span class="Bold">Use caution in the sun.</span> When outside, even on hazy 
days, areas treated with RETIN-A should be protected. An effective sunscreen 
should be used <span class="Underline">any time you are outside</span> (consult 
your physician for a recommendation of an SPF level which will provide you with 
the necessary high level of protection). For extended sun exposure, protective 
clothing, like a hat, should be worn. Do not use artificial sunlamps while you 
are using RETIN-A. If you do become sunburned, stop your therapy with RETIN-A 
until your skin has recovered.</p>
<p><span class="Bold">Avoid excessive exposure to <span class="product-label-link" type="condition" conceptid="4221803" conceptname="Flatus">wind</span> or <span class="product-label-link" type="condition" conceptid="260427" conceptname="Common cold">cold</span>.</span> Extremes of 
climate tend to dry or burn normal skin. Skin treated with RETIN-A may be more 
vulnerable to these extremes. Your physician can recommend ways to manage your 
<span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">acne</span> treatment under such conditions.</p>
<p><span class="Bold">Possible problems.</span> The skin of certain sensitive 
individuals may become excessively red, swollen, blistered or crusted. If you 
are experiencing severe or persistent irritation, discontinue the use of RETIN-A 
and consult your physician.</p>
<p>There have been reports that, in some patients, areas treated with RETIN-A 
developed a temporary increase or decrease in the amount of skin pigment (color) 
present. The pigment in these areas returned to normal either when the skin was 
allowed to adjust to RETIN-A or therapy was discontinued.</p>
<p><span class="Bold">Use other medication only on your physician's advice.</span> 
Only your physician knows which other medications may be helpful during 
treatment and will recommend them to you if necessary. Follow the physician's 
instructions carefully. In addition, you should avoid preparations that may dry 
or irritate your skin. These preparations may include certain astringents, 
toiletries containing alcohol, spices or lime, or certain medicated soaps, 
shampoos and hair permanent solutions. Do not allow anyone else to use this 
medication.</p>
<p>Do not use other medications with RETIN-A which are not recommended by your 
doctor. The medications you have used in the past might cause unnecessary 
<span class="product-label-link" type="condition" conceptid="137193" conceptname="Erythema">redness</span> or <span class="product-label-link" type="condition" conceptid="4032013" conceptname="Desquamation">peeling</span>.</p>
<p><span class="Bold">If you are pregnant, think you are pregnant or are nursing 
an infant:</span> No studies have been conducted in humans to establish the 
safety of RETIN-A in pregnant women. If you are pregnant, think you are 
pregnant, or are nursing a baby, consult your physician before using this 
medication.</p>
<p><span class="Bold">GELS ARE FLAMMABLE.</span> Note: Keep away from heat and 
flame. Keep tube tightly closed.</p>
<p><span class="Bold">AND WHILE YOU'RE ON RETIN-A THERAPY</span></p>
<p><span class="Italics">Use a mild, non-medicated soap. Avoid frequent washings 
and harsh scrubbing.</span> <span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">Acne</span> isn't caused by dirt, so no matter how hard you 
scrub, you can't wash it away. Washing too frequently or scrubbing too roughly 
may at times actually make your <span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">acne</span> worse. Wash your skin gently with a mild, 
bland soap. Two or three times a day should be sufficient. Pat <span class="product-label-link" type="condition" conceptid="4039266" conceptname="Dry skin">skin dry</span> with a 
towel. Let the face dry 20 to 30 minutes before applying RETIN-A. Remember, 
excessive irritation such as rubbing, too much washing, use of other medications 
not suggested by your physician, etc., may worsen your <span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">acne</span>.</p>
<br><br><p><span class="Bold">HOW TO USE RETIN-A (TRETINOIN)</span></p>
<p>To get the best results with RETIN-A therapy, it is necessary to use it 
properly. Forget about the instructions given for other products and the advice 
of friends. Just stick to the special plan your doctor has laid out for you and 
be patient. Remember, when RETIN-A is <span class="Italics">used properly,</span> 
many users see improvement by 12 weeks. AGAIN, FOLLOW INSTRUCTIONS â€“ BE PATIENT 
â€“ DON'T START AND STOP THERAPY ON YOUR OWN â€“ IF YOU HAVE QUESTIONS, ASK YOUR 
DOCTOR.</p>
<br><p>To help you use the medication correctly, keep these simple instructions in mind.<img alt="image of face" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=0ee4fccd-087f-4134-9b66-1d5186c116c0&amp;name=face.jpg"></p>
<ul>
<li>Apply RETIN-A once daily before bedtime, or as directed by your physician. 
Your physician may advise, especially if your skin is sensitive, that you start 
your therapy by applying RETIN-A every other night. First, wash with a mild soap 
and dry your skin gently.WAIT 20 to 30 MINUTES BEFORE APPLYING MEDICATION; it is 
important for skin to be completely dry in order to minimize possible 
irritation.</li>
<li>It is better not to use more than the amount suggested by your physician or 
to apply more frequently than instructed.Too much may irritate the skin, waste 
medication and won't give faster or better results.</li>
<li>Keep the medication away from the corners of the nose, mouth, eyes and open 
<span class="product-label-link" type="condition" conceptid="4029919" conceptname="Wound">wounds</span>. <span class="Italics">Spread away from these areas when applying.</span>
</li>
<li>
<span class="Italics">Cream:</span> Squeeze about a half inch or less of 
medication onto the fingertip. While that should be enough for your whole face, 
after you have some experience with the medication you may find you need 
slightly more or less to do the job. The medication should become invisible 
almost immediately. If it is still visible, you are using too much. Cover the 
affected area lightly with RETIN-A (tretinoin) Cream by first dabbing it on your 
forehead, chin and both cheeks, then spreading it over the entire affected area. 
Smooth gently into the skin.</li>
<li>
<span class="Italics">Gel:</span> Squeeze about a half inch or less of 
medication onto the fingertip. While that should be enough for your whole face, 
after you have some experience with the medication you may find you need 
slightly more or less to do the job. The medication should become invisible 
almost immediately. If it is still visible, or if dry flaking occurs from the 
gel <span class="Bold">within a minute or so,</span> you are using too much. Cover 
the affected area lightly with RETIN-A (tretinoin) Gel by first dabbing it on 
your forehead, chin and both cheeks, then spreading it over the entire affected 
area. Smooth gently into the skin.</li>
<li>
<span class="Italics">Liquid:</span> RETIN-A (tretinoin) Liquid may be applied 
to the skin where <span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">acne</span> lesions appear, spreading the medication over the entire 
affected area, using a fingertip, gauze pad, or cotton swab. If gauze or cotton 
is employed, care should be taken not to oversaturate it to the extent that the 
liquid would run into areas where treatment is not intended (such as corners of 
the mouth, eyes, and nose).</li>
<li>It is recommended that you apply a moisturizer or a moisturizer with 
sunscreen that will not aggravate your <span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">acne</span> (noncomedogenic) every morning after 
you wash.</li>
</ul>
<p><span class="Bold">WHAT TO EXPECT WITH YOUR NEW TREATMENT</span></p>
<p>RETIN-A works deep inside your skin and this takes time. You cannot make 
RETIN-A work any faster by applying more than one dose each day, but an excess 
amount of RETIN-A may irritate your skin. Be patient.</p>
<p>There may be some <span class="product-label-link" type="condition" conceptid="4090431" conceptname="Discomfort">discomfort</span> or <span class="product-label-link" type="condition" conceptid="4032013" conceptname="Desquamation">peeling</span> during the early days of treatment. 
Some patients also notice that their skin begins to take on a blush.</p>
<p>These reactions do not happen to everyone. If they do, it is just your skin 
adjusting to RETIN-A and this usually subsides within two to four weeks. These 
reactions can usually be minimized by following instructions carefully. Should 
the effects become excessively troublesome, consult your doctor.</p>
<p>BY THREE TO SIX WEEKS, some patients notice an appearance of new blemishes 
(<span class="product-label-link" type="condition" conceptid="4105835" conceptname="Papule">papules</span> and <span class="product-label-link" type="condition" conceptid="4158333" conceptname="Pustule">pustules</span>). At this stage it is <span class="Italics">important to 
continue</span> using RETIN-A.</p>
<p>If RETIN-A is going to have a beneficial effect for you, you should notice a 
continued improvement in your appearance after 6 to 12 weeks of therapy. Don't 
be discouraged if you see no immediate improvement. Don't stop treatment at the 
first signs of improvement.</p>
<p>Once your <span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">acne</span> is under control you should continue regular application of 
RETIN-A until your physician instructs otherwise.</p>
<p><span class="Bold">IF YOU HAVE QUESTIONS</span></p>
<p>All questions of a medical nature should be taken up with your doctor. For 
more information about RETIN-A (tretinoin), call our toll-free number: 
800-426-7762. Call between 9:00 a.m. and 3:00 p.m. Eastern Time, Monday through 
Friday.</p>
<br><br><br><p>ORTHO DERMATOLOGICAL</p>
<p>Division of Ortho-McNeil</p>
<p>Pharmaceutical, Inc.</p>
<p>Skillman, New Jersey 08558</p>
<p>Â©OMP 2001 Revised February 2001 Printed in U.S.A. 643-10-490-9</p>
<br>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="section-12"></a><p></p>
<h1>PRINCIPAL DISPLAY PANEL</h1>
<p class="First">Retin-A<span class="Sup">Â®</span><br>(tretinoin)</p>
<p>0.025% Cream</p>
<div class="Figure"><img alt="image of 0.025% Cream package label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=0ee4fccd-087f-4134-9b66-1d5186c116c0&amp;name=package%20label%2001.jpg"></div>
<p><br></p>
<p>Retin-A<span class="Sup">Â®</span><br>(tretinoin)</p>
<p>0.025% Gel</p>
<div class="Figure"><img alt="image of 0.025% Gel package label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=0ee4fccd-087f-4134-9b66-1d5186c116c0&amp;name=package%20label%2002.jpg"></div>
<p><br></p>
<p>Retin-A<span class="Sup">Â®</span><br>(tretinoin)</p>
<p>0.05% Cream</p>
<div class="Figure"><img alt="image of 0.05% Cream package label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=0ee4fccd-087f-4134-9b66-1d5186c116c0&amp;name=package%20label%2003.jpg"></div>
<p><br></p>
<p>Retin-A<span class="Sup">Â®</span><br>(tretinoin)</p>
<p>0.1% Cream</p>
<div class="Figure"><img alt="image of 0.1% Cream package label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=0ee4fccd-087f-4134-9b66-1d5186c116c0&amp;name=package%20label%2004.jpg"></div>
<p><br></p>
<p>Retin-A<span class="Sup">Â®</span><br>(tretinoin)</p>
<p>0.1% Gel</p>
<p><img alt="image of 0.1% Gel package label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=0ee4fccd-087f-4134-9b66-1d5186c116c0&amp;name=package%20label%2005.jpg"></p>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>RETIN-AÂ 		
					</strong><br><span class="contentTableReg">tretinoin cream</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:54868-1760(NDC:0062-0165)</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">TOPICAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">Â Â Â Â 
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>TRETINOIN</strong> (TRETINOIN) </td>
<td class="formItem">TRETINOIN</td>
<td class="formItem">0.25Â mg Â inÂ 1Â g</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>STEARIC ACID</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>ISOPROPYL MYRISTATE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>POLYOXYL 40 STEARATE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>STEARYL ALCOHOL</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>XANTHAN GUM</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>SORBIC ACID</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>BUTYLATED HYDROXYTOLUENE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>WATER</strong></td>
<td class="formItem">Â </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:54868-1760-1</td>
<td class="formItem">20 g in 1 TUBE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem">NDC:54868-1760-2</td>
<td class="formItem">45 g in 1 TUBE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">NDA</td>
<td class="formItem">NDA019049</td>
<td class="formItem">05/28/1993</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>RETIN-AÂ 		
					</strong><br><span class="contentTableReg">tretinoin gel</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:54868-0270(NDC:0062-0475)</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">TOPICAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">Â Â Â Â 
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>TRETINOIN</strong> (TRETINOIN) </td>
<td class="formItem">TRETINOIN</td>
<td class="formItem">0.25Â mg Â inÂ 1Â g</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>BUTYLATED HYDROXYTOLUENE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>HYDROXYPROPYL CELLULOSE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>ALCOHOL</strong></td>
<td class="formItem">Â </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:54868-0270-1</td>
<td class="formItem">45 g in 1 TUBE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">NDA</td>
<td class="formItem">NDA017579</td>
<td class="formItem">05/25/1993</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>RETIN-AÂ 		
					</strong><br><span class="contentTableReg">tretinoin cream</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:54868-0267(NDC:0062-0175)</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">TOPICAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">Â Â Â Â 
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>TRETINOIN</strong> (TRETINOIN) </td>
<td class="formItem">TRETINOIN</td>
<td class="formItem">0.5Â mg Â inÂ 1Â g</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>STEARIC ACID</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>ISOPROPYL MYRISTATE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>POLYOXYL 40 STEARATE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>STEARYL ALCOHOL</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>XANTHAN GUM</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>SORBIC ACID</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>BUTYLATED HYDROXYTOLUENE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>WATER</strong></td>
<td class="formItem">Â </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:54868-0267-1</td>
<td class="formItem">20 g in 1 TUBE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem">NDC:54868-0267-2</td>
<td class="formItem">45 g in 1 TUBE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">NDA</td>
<td class="formItem">NDA017522</td>
<td class="formItem">01/01/1996</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>RETIN-AÂ 		
					</strong><br><span class="contentTableReg">tretinoin cream</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:54868-0268(NDC:0062-0275)</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">TOPICAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">Â Â Â Â 
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>TRETINOIN</strong> (TRETINOIN) </td>
<td class="formItem">TRETINOIN</td>
<td class="formItem">0.1Â mg Â inÂ 1Â g</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>STEARIC ACID</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>ISOPROPYL MYRISTATE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>POLYOXYL 40 STEARATE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>STEARYL ALCOHOL</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>XANTHAN GUM</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>SORBIC ACID</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>BUTYLATED HYDROXYTOLUENE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>WATER</strong></td>
<td class="formItem">Â </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:54868-0268-1</td>
<td class="formItem">20 g in 1 TUBE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem">NDC:54868-0268-2</td>
<td class="formItem">45 g in 1 TUBE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">NDA</td>
<td class="formItem">NDA017340</td>
<td class="formItem">08/21/1996</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>RETIN-AÂ 		
					</strong><br><span class="contentTableReg">tretinoin gel</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:54868-0269(NDC:0062-0575)</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">TOPICAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">Â Â Â Â 
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>TRETINOIN</strong> (TRETINOIN) </td>
<td class="formItem">TRETINOIN</td>
<td class="formItem">0.1Â mg Â inÂ 1Â g</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>BUTYLATED HYDROXYTOLUENE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>HYDROXYPROPYL CELLULOSE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>ALCOHOL</strong></td>
<td class="formItem">Â </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:54868-0269-2</td>
<td class="formItem">15 g in 1 TUBE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">NDA</td>
<td class="formItem">NDA017955</td>
<td class="formItem">05/25/1993</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler -Â </span>Physicians Total Care, Inc.
							(194123980)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Physicians Total Care, Inc.</td>
<td class="formItem"></td>
<td class="formItem">194123980</td>
<td class="formItem">relabel</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 4/2010<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>ed20f459-3294-4acc-b50f-9928ff55e743</div>
<div>Set id: 0ee4fccd-087f-4134-9b66-1d5186c116c0</div>
<div>Version: 1</div>
<div>Effective Time: 20100427</div>
</div>
</div>Â <div class="DistributorName">Physicians Total Care, Inc.</div></p>
</body></html>
